Risk Models for Breast Cancer and Their Validation.
Breast cancer
IBIS model
Tyrer–Cuzick model
breast density
calibration
risk assessment
Journal
Statistical science : a review journal of the Institute of Mathematical Statistics
ISSN: 0883-4237
Titre abrégé: Stat Sci
Pays: United States
ID NLM: 100962994
Informations de publication
Date de publication:
03 Mar 2020
03 Mar 2020
Historique:
entrez:
1
4
2020
pubmed:
1
4
2020
medline:
1
4
2020
Statut:
ppublish
Résumé
Strategies to prevent cancer and diagnose it early when it is most treatable are needed to reduce the public health burden from rising disease incidence. Risk assessment is playing an increasingly important role in targeting individuals in need of such interventions. For breast cancer many individual risk factors have been well understood for a long time, but the development of a fully comprehensive risk model has not been straightforward, in part because there have been limited data where joint effects of an extensive set of risk factors may be estimated with precision. In this article we first review the approach taken to develop the IBIS (Tyrer-Cuzick) model, and describe recent updates. We then review and develop methods to assess calibration of models such as this one, where the risk of disease allowing for competing mortality over a long follow-up time or lifetime is estimated. The breast cancer risk model model and calibration assessment methods are demonstrated using a cohort of 132,139 women attending mammography screening in the State of Washington, USA.
Identifiants
pubmed: 32226220
doi: 10.1214/19-STS729
pmc: PMC7100774
mid: EMS85958
doi:
Types de publication
Journal Article
Langues
eng
Pagination
14-30Subventions
Organisme : NCI NIH HHS
ID : N01 CN067009
Pays : United States
Organisme : NCI NIH HHS
ID : P01 CA154292
Pays : United States
Organisme : Cancer Research UK
ID : A16891
Pays : United Kingdom
Organisme : NCI NIH HHS
ID : HHSN261201300012I
Pays : United States
Organisme : NCI NIH HHS
ID : N01PC35142
Pays : United States
Organisme : NCI NIH HHS
ID : R50 CA211115
Pays : United States
Organisme : NCI NIH HHS
ID : HHSN261201000029C
Pays : United States
Organisme : NCI NIH HHS
ID : N01 CN005230
Pays : United States
Organisme : NCI NIH HHS
ID : HHSN261201100031C
Pays : United States
Références
Biometrics. 2017 Jun;73(2):473-482
pubmed: 27554303
J Natl Cancer Inst. 2011 Feb 16;103(4):284-5
pubmed: 21278357
Obes Rev. 2018 Feb;19(2):254-268
pubmed: 29130623
JAMA Oncol. 2018 Nov 1;4(11):e181771
pubmed: 29931120
Am J Hum Genet. 2019 Jan 3;104(1):21-34
pubmed: 30554720
Breast Cancer Res. 2015 Dec 01;17(1):147
pubmed: 26627479
N Engl J Med. 2015 Jun 4;372(23):2243-57
pubmed: 26014596
Int Stat Rev. 1987 Apr;55(1):1-20
pubmed: 12179583
Br J Cancer. 2002 Jan 7;86(1):76-83
pubmed: 11857015
JAMA Oncol. 2018 Apr 1;4(4):476-482
pubmed: 29346471
J Natl Cancer Inst. 1999 Sep 15;91(18):1541-8
pubmed: 10491430
Cancer. 1969 Dec;24(6):1146-51
pubmed: 5353960
Lancet Oncol. 2010 Dec;11(12):1127-34
pubmed: 21093374
J Natl Cancer Inst. 1989 Dec 20;81(24):1879-86
pubmed: 2593165
Breast Cancer Res Treat. 2013 Feb;137(3):869-82
pubmed: 23274845
Lancet Oncol. 2015 Jan;16(1):67-75
pubmed: 25497694
J Clin Oncol. 2010 Aug 1;28(22):3591-6
pubmed: 20606088
PLoS Med. 2018 Sep 4;15(9):e1002644
pubmed: 30180161
Stat Med. 2004 Apr 15;23(7):1111-30
pubmed: 15057881
N Engl J Med. 2010 Mar 18;362(11):986-93
pubmed: 20237344
Breast Cancer Res Treat. 2012 Feb;132(1):347-53
pubmed: 22147080
Breast Cancer Res Treat. 2017 Nov;166(1):227-240
pubmed: 28702896
Br J Cancer. 1982 Feb;45(2):185-93
pubmed: 7059469
Am J Epidemiol. 2000 Dec 15;152(12):1154-63
pubmed: 11130621
Ann Intern Med. 2008 Mar 4;148(5):337-47
pubmed: 18316752
J Natl Cancer Inst. 2006 Sep 6;98(17):1215-26
pubmed: 16954474
Stat Med. 1996 Feb 28;15(4):361-87
pubmed: 8668867
J Clin Oncol. 2007 Jul 1;25(19):2671-7
pubmed: 17563394
CA Cancer J Clin. 2007 Mar-Apr;57(2):75-89
pubmed: 17392385
Lancet Oncol. 2012 Nov;13(11):1141-51
pubmed: 23084519
JAMA. 2006 Feb 8;295(6):629-42
pubmed: 16467232
Am J Hum Genet. 1998 Jan;62(1):145-58
pubmed: 9443863
J Natl Cancer Inst. 2001 Mar 7;93(5):358-66
pubmed: 11238697
J Med Genet. 2003 Nov;40(11):807-14
pubmed: 14627668
Lancet Oncol. 2006 Nov;7(11):910-8
pubmed: 17081916
Stat Methods Med Res. 2016 Aug;25(4):1692-706
pubmed: 23907781
Breast Cancer Res Treat. 2013 Nov;142(1):187-202
pubmed: 24158759
N Engl J Med. 2007 Jan 18;356(3):227-36
pubmed: 17229950
Biostatistics. 2005 Apr;6(2):227-39
pubmed: 15772102
Cancer Epidemiol Biomarkers Prev. 2006 Jun;15(6):1159-69
pubmed: 16775176
J Natl Cancer Inst. 2015 Mar 04;107(5):
pubmed: 25745020
Breast Cancer Res. 2014 Oct 08;16(5):451
pubmed: 25292294
Lifetime Data Anal. 1996;2(4):315-28
pubmed: 9384628
J Natl Cancer Inst. 2016 Dec 20;109(2):
pubmed: 28003316
Br Med Bull. 1991 Apr;47(2):504-18
pubmed: 1933230
Cancer Epidemiol Biomarkers Prev. 2005 Dec;14(12):2905-13
pubmed: 16365008
J Breast Imaging. 2019 Jun;1(2):99-106
pubmed: 31423486
Breast Cancer Res Treat. 1993 Nov;28(2):115-20
pubmed: 8173064
J Clin Oncol. 2015 Oct 1;33(28):3137-43
pubmed: 26282663
J Natl Cancer Inst. 2010 Nov 3;102(21):1618-27
pubmed: 20956782
AJR Am J Roentgenol. 1976 Jun;126(6):1130-7
pubmed: 179369
JAMA Oncol. 2018 Sep 1;4(9):e180174
pubmed: 29621362
Nature. 1983 Jun 30;303(5920):767-70
pubmed: 6866078
Br J Cancer. 2008 Apr 22;98(8):1457-66
pubmed: 18349832
J Clin Oncol. 2017 Mar;35(7):743-750
pubmed: 28029312
Br J Cancer. 2002 Nov 18;87(11):1234-45
pubmed: 12439712
PLoS Med. 2012;9(5):e1001216
pubmed: 22675273
Breast Cancer Res. 2017 Oct 18;19(1):114
pubmed: 29047382
J Med Genet. 2017 Feb;54(2):111-113
pubmed: 27794048
Genet Med. 2016 Dec;18(12):1190-1198
pubmed: 27464310
J Natl Cancer Inst. 2006 Dec 6;98(23):1686-93
pubmed: 17148770
Am J Hum Genet. 1998 Mar;62(3):676-89
pubmed: 9497246
Stat Med. 1987 Dec;6(8):881-4
pubmed: 3326103